Safety trial using the Leishmune ® vaccine against canine visceral leishmaniasis in Brazil
Safety trial using the Leishmune ® vaccine against canine visceral leishmaniasis in Brazil
About this item
Full title
Author / Creator
Publisher
Oxford: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
AbstractA group of 600 healthy and asymptomatic dogs from Brazilian canine visceral leishmaniasis endemic areas was vaccinated with three sc doses of Leishmune ® which is the industrialized formulation of the FML-saponin, recently licensed for commercialization in Brazil, which previously showed 76–80% vaccine efficacy against canine visceral leish...
Alternative Titles
Full title
Safety trial using the Leishmune ® vaccine against canine visceral leishmaniasis in Brazil
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20281639
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20281639
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2006.11.057
